British Journal of Cancer - Table of Contents alert Volume 114 Issue 8

If you are unable to see the message below, click here to view.

Advertisement ATTENDING AACR? MURPHY'S LAB WILL BE THERE! Everyone gets frustrated in the workplace, and we want to hear your gripes. Tell us what bothers you, and it might be featured in our next illustration. Stop by booth #2012 to pick up FREE Murphy's Lab merchandise. Date: Sunday, 17th April, 2016 Time: 1pm until supplies last Location: Nature booth #2012 LEARN MORE   TABLE OF CONTENTS Volume 114, Issue 8 (849-952) Published online 13 April 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top The clinical implications of gene mutations in chronic lymphocytic leukaemia Davide Rossi and Gianluca Gaidano Br J Cancer 2016 114: 849-854; advance online publication, March 31, 2016; 10.1038/bjc.2016.78 Abstract | Full Text Clinical Studies Top Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial Ulrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, Valentin Goede, Lars Schiffmann, Stefan J Scherer, Priti Hedge, Eric Van Cutsem, Oliver Coutelle and Hildegard Büning Br J Cancer 2016 114: 855-862; advance online publication, March 31, 2016; 10.1038/bjc.2016.30 Abstract | Full Text Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study W Janni, N Harbeck, B Rack, D Augustin, J Jueckstock, A Wischnik, K Annecke, C Scholz, J Huober, T Zwingers, T W P Friedl and M Kiechle Br J Cancer 2016 114: 863-871; advance online publication, March 31, 2016; 10.1038/bjc.2016.82 Abstract | Full Text Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients Angelica Loskog, Aglaia Maleka, Sara Mangsbo, Emma Svensson, Christina Lundberg, Anders Nilsson, Johan Krause, Margrét Agnarsdóttir, Anders Sundin, Håkan Ahlström, Thomas H Tötterman and Gustav Ullenhag Br J Cancer 2016 114: 872-880; advance online publication, March 31, 2016; 10.1038/bjc.2016.42 Abstract | Full Text Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy Toshikazu Moriwaki, Yoshiyuki Yamamoto, Masahiko Gosho, Mariko Kobayashi, Akinori Sugaya, Takeshi Yamada, Shinji Endo and Ichinosuke Hyodo Br J Cancer 2016 114: 881-888; advance online publication, March 31, 2016; 10.1038/bjc.2016.83 Abstract | Full Text A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies Joaquin Mateo, David Olmos, Herlinde Dumez, Srinivasu Poondru, Nancy L Samberg, Sharon Barr, Jan M Van Tornout, Fei Jie, Shahneen Sandhu, Daniel S Tan, Victor Moreno, Patricia M LoRusso, Stan B Kaye and Patrick Schöffski Br J Cancer 2016 114: 889-896; advance online publication, March 22, 2016; 10.1038/bjc.2016.59 Abstract | Full Text Translational Therapeutics Top Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling S Peter Johnson, Rajiv Ramasawmy, Adrienne E Campbell-Washburn, Jack A Wells, Mathew Robson, Vineeth Rajkumar, Mark F Lythgoe, R Barbara Pedley and Simon Walker-Samuel Br J Cancer 2016 114: 897-904; advance online publication, March 31, 2016; 10.1038/bjc.2016.51 Abstract | Full Text Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models Carlos Martínez-Pérez, Carol Ward, Arran K Turnbull, Peter Mullen, Graeme Cook, James Meehan, Edward J Jarman, Patrick IT Thomson, Colin J Campbell, Donald McPhail, David J Harrison and Simon P Langdon Br J Cancer 2016 114: 905-916; advance online publication, March 31, 2016; 10.1038/bjc.2016.6 Abstract | Full Text Molecular Diagnostics Top MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours Andrew R Green, Mohammed A Aleskandarany, Devika Agarwal, Somaia Elsheikh, Christopher C Nolan, Maria Diez-Rodriguez, R Douglas Macmillan, Graham R Ball, Carlos Caldas, Srinivasan Madhusudan, Ian O Ellis and Emad A Rakha Br J Cancer 2016 114: 917-928; advance online publication, March 8, 2016; 10.1038/bjc.2016.46 Abstract | Full Text Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry Dongjian Song, Lifang Yue, Hao Li, Junjie Zhang, Zechen Yan, Yingzhong Fan, Heying Yang, Qiuliang Liu, Da Zhang, Ziqiang Xia, Pan Qin, Jia Jia, Ming Yue, Jiekai Yu, Shu Zheng, Fuquan Yang and Jiaxiang Wang Br J Cancer 2016 114: 929-938; advance online publication, March 22, 2016; 10.1038/bjc.2016.52 Abstract | Full Text Genetics and Genomics Top Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression Rebecca E Graff, Allison Meisner, Thomas U Ahearn, Michelangelo Fiorentino, Massimo Loda, Edward L Giovannucci, Lorelei A Mucci and Andreas Pettersson for the Transdisciplinary Prostate Cancer Partnership (ToPCaP) Br J Cancer 2016 114: 939-944; advance online publication, March 17, 2016; 10.1038/bjc.2016.61 Abstract | Full Text Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array Edward J Saunders, Tokhir Dadaev, Daniel A Leongamornlert, Ali Amin Al Olama, Sara Benlloch, Graham G Giles, Fredrik Wiklund, Henrik Grönberg, Christopher A Haiman, Johanna Schleutker, Børge G Nordestgaard, Ruth C Travis, David Neal, Nora Pasayan, Kay-Tee Khaw, Janet L Stanford, William J Blot, Stephen N Thibodeau, Christiane Maier, Adam S Kibel, Cezary Cybulski, Lisa Cannon-Albright, Hermann Brenner, Jong Y Park, Radka Kaneva, Jyotsna Batra, Manuel R Teixeira, Hardev Pandha, Koveela Govindasami, Ken Muir, The UK Genetic Prostate Cancer Study Collaborators, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Douglas F Easton, Rosalind A Eeles and Zsofia Kote-Jarai Br J Cancer 2016 114: 945-952; advance online publication, March 10, 2016; 10.1038/bjc.2016.50 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.